About FDA
FY 2004 ODE Annual Report - Appendix B - ODE Publications
The following is a bibliography of articles and abstracts prepared by the ODE staff and published or presented during FY 2004.
Journals, Newsletter Articles and Book Chapters
Abel DB. FDA Insights: IDE Progress Reports. Endovasc Today 3(7):85-87, 2004.
Abel DB and Proestel SE. FDA Insights: Optimizing Registry Data Presentation. Endovasc Today 3(6):58-59, 2004.
Abel DB. Premarket Approval and Premarket Notification. Endovasc Today 3(4):53-54, 2004.
Abel DB. FDA Insights: What the CDRH Doesn’t Do. Endovasc Today 3(3):78-80, 2004.
Abel DB and Smith AC. FDA Insights: How to (or Not to) Impede FDA Reviews. Endovasc Today 3(2):70-71, 2004.
Abel DB. FDA Insights: What to Expect When You are Inspected. Endovasc Today 3(1):58-60, 2004.
Abel DB and Pilcher GP. FDA Insights: Medical Device User Fee and Modernization Act. Endovasc Today 2(7):55-57, 2003.
Abel DB. FDA Insights: Top 10 Issues and Insights for Endovascular Grafts. Endovasc Today 2(8):68-69, 2003.
Abel DB and Smith A. How to (Or Not to) Impede FDA Reviews, Endovasc Today 3(2):70-71, February 2004.
Chakrabarti K, Kaczmarek R, Thomas J and Romanyukha A. Effect of Room Illuminance on Monitor Black Level Luminance and Monitor Calibration. Journal of Digital Imaging 16(4):350-355, 2003.
Drum B. FDA Regulation of Labeling and Promotional Claims in Therapeutic Color Vision Devices: a Tutorial. Visual Neurosci. 21(3):461-463, 2004.
Drum B and Hilmantel G. Retinal Nerve Fiber Loss after Acute Intraocular Pressure Elevation. J Cataract Refract. Surg. 29(12):2255-2257, 2003.
Mezu-Nwaba N. Public Health Initiative in Nigeria, available on the Public Health Pharmacy Subcommittee website, December 29, 2003 – January 1, 2004.
Reefhuis J, Mann EA, and Whitney CG. Bacterial meningitis in children with cochlear implants (letter to the editor). New Engl J Med 349(18):1772-1773, 2003.
Sataloff RT, Mandel S, Mann E, and Ludlow C. Practice parameter: Laryngeal electromyography (an evidence based review). J Voice 18(2):261-274, 2004.
Sataloff RT, Mandel S, Mann E, and Ludlow C. Practice parameter: Laryngeal electromyography (an evidence based review). Otolaryngol Head Neck Surg 130(6):770-779, 2004.
Saviola J. Post-Approval Clinical Studies: A Useful Tool for Answering Difficult Questions. Review of Contact Lenses pg. 30-33, June 2004.
Saviola J. The FDA and Contact Lenses Contact. Review of Contact Lenses pg.32-37, January 2004.
Stewart SFC, Herman BA, Nell DM, and Retta SM. Effects of Valve Characteristics on the Accuracy of the Bernoulli Equation: A Survey of Data Submitted to the U.S. FDA. J. Heart Valve Disease 13(3):461-466, May 2004.
Abstracts and Presentations
Abel DB. Presented talks and moderated the entire 2004 FDA Workshop on Pre-Clinical Testing for Endovascular Grafts. Gaithersburg, MD, July 28-29, 2004.
Abel DB. Moving Technology into the Clinical Setting and Commercialization. Challenges in Engineering: The Aorta, Carotid & SFA. SVS, Anaheim, CA, June 2, 2004.
Abel DB. Update on Requirements for Endovascular Grafts. Regulatory Pathways for Medical Device Approvals: A Workshop with the FDA. CRT 2004, Washington, DC, May 6, 2004.
Abel DB. The Regulatory Environment: USA and Regulatory Challenges: The Regulator’s Perspective. Charing Cross Symposium 2004, London, England, April 6, 2004.
Abel DB. To Device Licensure and Beyond. 2004 Joan L. and Julius H. Jacobson Research Initiatives in Vascular Disease Conference: "Translational Vascular Research: From Bench to Bedside to Boardroom," Bethesda, MD, April 2, 2004.
Abel DB. Endovascular Approaches to AAA: Update from the FDA. 26th World Congress of the International Society for Cardiovascular Surgery, Maui, HW, March 24, 2004.
Abel DB. Regulation of Endovascular Grafts: Lessons and Concerns from the Last Few Years. International Symposium on Endovascular Therapy, Miami, FL, January 28, 2004.
Abel DB, Grunwaldt M, and Smith A. 2004 FDA Workshop on Pre-Clinical Testing for Endovascular Grafts, Gaithersburg, MD, July 28-29, 2004.
Anderson J. Total Artificial Discs: A Regulatory Prospective. Pre-Meeting Course Instructor, North American Spine Society, San Diego, CA, October 21, 2003.
Baker K. Ear, Nose and Throat Medical Devices: A Regulatory Perspective. Presented at the 28th Annual Congress and Nursing Symposium of the Society of Otolaryngology and Head-Neck Nurses, New York, NY, September 19, 2004.
Berman M. Defining Device Safety: FDA Perspective. Heart Failure Society of America Workshop, Washington, DC, April 2004.
Buckles D, Aguel F, Brockman R, Cheng J, Demian C, Ho C, Jensen D, and Mallis E. Advances in Ambulatory Monitoring: Regulatory Considerations, 29th Annual Conference of the International Society of Computerized Electrocardiology, Hutchinson Island, FL, April 27 - May 2, 2004.
Carey CC. Innovations in AED Technology: The Need for Clinical Data. The 7th Wolf Creek Conference on Cardiopulmonary Resuscitation, Rancho Mirage, CA, June 13-16, 2003.
Cavanaugh KJ. FDA Recommendations for Peripheral DES: Non-clinical testing" – Cardiovascular Revascularization Therapies, Washington, DC, May 2004.
Cavanaugh KJ. FDA Panel Discussion. Cleveland Clinic Stent Summit, Cleveland, OH, August 2004.
Chakrabarti K, Thomas J, Kaczmarek R, Maslennikov A, and Romanyukha A. Intraobserver Variability Between CRT and Flat Panel Displays. Annual Meeting of American Association of Physicists in Medicine, Pittsburgh, PA, July 25-29, 2004.
Chakrabarti K, Thomas J, Kaczmarek R, Maslennikov A, and Romanyukha A. Display Performance and Object Detection Variation with Viewing Angle On CRT and LCD Displays. Annual Meeting of American Association of Physicists in Medicine, Pittsburgh, PA, July 25-29, 2004.
Chakrabarti K, Gagne R, Thomas J, Gallas B, and Myers K. Toward Objective Evaluation of Imaging Phantom Scores – ACR/MAP. Annual Meeting of American Association of Physicists in Medicine, Pittsburgh, PA, July 25-29, 2004.
Chen E. Left Ventricular Assist Devices FDA's Perspective - Taiwan 2004.
Ciarkowski A. Medical Device Display. Smithsonian Institution’s program to celebrate
National Girl Scout Day, Washington, DC, March 6, 2004.
Ciarkowski A. Medical Device Life Cycle. American Society for Artificial Internal Organs, Washington, DC, June 16, 2004.
Ciarkowski A. Innovatiions in Device Regulation. International Center for Medical Technology, Washington, DC, June 19, 2004.
Demian H. Regulatory Perspective for the Scientific Review Process for Orthopedic Bone Cements. OUS Biotech, Sidney, Australia, May 20, 2004.
Demian H. Regulations of Tissue Based Devices. 7th World Biomaterials Congress, Sidney, Australia, May 22, 2004.
Drum B and Eydelman M. Systematic Evaluation of Wavefront-Guided Outcomes. 5th International Congress on Wavefront Sensing and Optimized Refractive Corrections, Whistler, BS, Canada, February 21-23, 2004.
Eydelman M and Rosenthal AR. A Guide to Ophthalmic Device and Drug Evaluation. AAO Course, Annaheim, CA, November 16, 2003.
Eydelman M and Rosenthal AR. FDA – Dispelling the Myth. ASCRS Symposium, San Diego, CA, May 3, 2004.
Eydelman M. Key Elements for Device Evaluation Protocols. AdvaMed MTLI Audio Conference entitled CDRH Reviewer’s Perspectives on Clinical Trial Design, Conduct and Reporting, Rockville, MD, August 4, 2004.
Fleischer D. The 510(k) Review Process. Heart Failure Society of America Workshop, Washington, DC, April 2004.
Fleischer D. How Does FDA Review Ventricular Assist Devices, Cleveland Clinic Site Visit, Cleveland, OH, December 2003
Gantt AD. Overview of the US FDA Regulatory Process. Satellite Meeting Sponsored by Australian Medical Device Forum in conjunction with World Biomaterials Congress, Sydney, Australia, May 22, 2004.
Gantt AD. Regulatory Considerations for the Introduction of New or Modified Biomaterials in the United States, World Biomaterials Congress, Sydney, Australia, May 21, 2004.
Gonzalez G, Nipper JC, Yustein AS, Olvey KM, Dart LL, Cooper JW, Straughn KA, Neuland CY. The use of a Biliary Stent Clearance Database in the Review of Biliary Stents for Malignant Neoplasms – Abstract – FDA Science Forum, Washington, DC, April 2004.
Goode JL. Drug Eluting Stents: Regulatory Approach and Non-Clinical Testing Issues. RAPS 2003 Annual Meeting, Baltimore, MD, October 22, 2003.
Goode JL. FDA Recommendations for Superficial Femoral Artery, Drug Eluting Stent: Clinical Trial Issues. CRT 2004 Annual Meeting, Washington, DC, May 6, 2004.
Goode JL. Peripheral DES: Similarities to and Differences from Coronary DES. TCT 2004 Annual Meeting, Washington, DC, September 29, 2004.
Herrera H. Technical Aspects of Continence Devices. 3rd International Consultation on Incontinence, Monaco, June 25 – July 1, 2004.
Ho C and Kurtzman SB. Issues in using databases of pre-recorded physiological signals to test medical devices, 2004 FDA Science Forum, Washington, DC, May 18-19, 2004.
Hottenstein OD. FDA Overview: Approval Process and Status of Carotid Stent Systems. Course: Current evaluation and management of extra-cranial carotid disease: The status of Carotid Stenting. American College of Cardiology Foundation. Miami, FL, March 25, 2004.
Hottenstein OD. We are the FDA and we are here to help: IDE, PMA, 510(k). 13th Annual Peripheral Angioplasty and All that Jazz Symposia, Interventional Cardiology Research Foundation, New Orleans, LA, April 15, 2004.
Hottenstein OD. FDA recommendations for Carotid Stenting & Embolic Protection: Clinical Trial Design & Regulatory Issues. Regulatory Pathways for medical device approvals: A workshop with the FDA. CRT 2004 Cardiovascular Revascularization Therapy 2004, Washington, DC, May 13, 2004.
Jensen N. Evaluating Methods to Diagnose and Treat Vulnerable Plaque – the FDA Perspective. Presenter at NHLBI – Center for Integration of Medicine and Innovative Technology (CIMIT) Workshop: Challenges and Opportunities in Managing the Vulnerable Atherosclerotic Plaque, Bethesda, MD, January 25-26, 2004.
Jensen N. Cardiac Catheters for Delivery of Cell Suspensions. CBER Advisory Panel Meeting: Cellular Products for the Treatment of Cardiac Disease, Silver Spring, MD, March 18-19, 2004.
Jensen N. Devices Intended to Diagnose Vulnerable Plaque. Cardiovascular Revascularization Therapy conference, Washington, DC, May 5-7, 2004.
Jensen N. Natural History and Therapy and Therapy Studies for Vulnerable Plaque. TCT Health & Human Services Town Hall, Washington, DC, September 29, 2004.
Lauritsen K. Rotational Opportunities for Emerging Leaders at FDA. Orientation for the Emerging Leaders Program, Rockville, MD, July 28, 2004.
Lochner D. Humanitarian Use Devices and the Humanitarian Device Exemptions Process. Transcatheter Cardiovascular Therapeutics, Washington, DC, September 29, 2004.
Mattamal GJ. U.S. FDA Perspective on the Regulations of Cyanoacrylate Polymer Tissue Adhesives in Clinical Applications. Medical Design and Manufacturing Meeting, Anaheim, CA, January 6, 2004.
Mattamal GJ. U.S. perspective on Regulations of Medical Device Tissue Adhesives, in Particular Cyanoacrylate Polymer Tissue Adhesives. ASM International Materials and Processes for Medical Devices Conference, St. Paul, MN, August 27, 2004.
Melkerson M and Stevens T. Orthopedic and Restorative Update. Orthopaedic Surgical Devices Manufacturer’s Association, Annapolis, MD, April 16, 2004.
Mezu-Nwaba N. Pharmacy Volunteerism. Pharmacist Professional Advisory Committee (PharmPAC) Public Health Pharmacy Subcommittee Pharmacy Volunteerism, Rockville, MD, March 4, 2004.
Morris J. Panel Discussion: Alternative Trial Designs (Prostate Cancer); Image – Guided Interventions: Trial Design Methodology Workshop, Alexandria, VA, February 2, 2004.
Morris J. Device-Related Infections, Surgical Interventions, Medical Advances and Regulatory Perspectives. 4th Annual Conference of CPI and MADRI, San Antonio, TX,
August 6 – August 8, 2004.
Morris J. Regulatory Considerations for Medical Devices with Antimicrobials. Center for Biofilm Engineering, Technical Advisory Conference, Bozeman, MT, June 29 – July 1, 2004.
Muni NI, Ho C, and Mallis E. Regulatory Issues for Computerized Electrocardiographic Devices. 29th Annual Conference of the International Society of Computerized Electrocardiology, Hutchinson Island, FL, April 27 - May 2, 2004.
Neuland C. FDA Approval Process for Medical Devices: Getting a New Device from Bench to Bedside. 68th Annual Scientific Meeting of the American College of Gastroenterology (ACG): Breakfast Session, Baltimore, MD, October 14, 2003.
Ogden N and Ashar B. Image-guided Interventions: Trial Design Methodology Workshop. Methodological Issues: Regulatory Perspective, Alexandria, VA, February 2-3, 2004.
O’Lone MT. SARS and Hospital Infection Control. Taiwan Department of Health Workshop “Sterilization and Infection Control in Healthcare Settings,” Taiwan, October 2003.
Pena C, Bowsher K, and Samuels-Reid J. FDA Approved Neurological Devices for Infants, Children, and Adolescents. FDA Science Forum Annual Meeting. Washington DC, April 2004.
Pena C. Career Opportunities at FDA. NIH Student and Fellows Workshop, National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, June 18, 2004.
Pena C. IDE Regulations. Program Director’s Staff Meeting, National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, July 21, 2004.
Pena C and Schlosser M. Intercenter Stroke Meeting. Stroke Treatment: FDA Staff Roundup and Round Tale Discussions, Rockville, MD, September 22, 2004.
Phillips PJ, Gardner S, Albersheim H, Berman S, Duggirala HJ, Eakle M, Janes P, Jones P, Mendelson M, Pinkos A, Warner M, Wollerton MA, Weick Brady M, and Ciarkowski A. Development of Policies to Manage Risks Associated with Increasing Use of Medical Devices in the Home. Poster at the FDA Science Forum, Washington, DC, May 18-20, 2004.
Pluhowski NJ. Advisory Panel Review. RAPS PMA Webcast Series, Rockville, MD, February 4, 2004.
Pluhowski NJ. CDRH Advisory Panel Update. 7th Annual FDA-Orange County Regulatory Affairs Educational Conference, Irvine, CA, June 2-3, 2004.
Pollard C. Development of Medical Devices: Regulatory Considerations for ART Devices. FDA Workshop at annual meeting of ASRM, San Antonio, TX, October 14, 2003.
Pollard C. Medical Devices: Regulatory Considerations re: Devices used for Women’s Health. Annual meeting of ASRM, San Antonio, TX, October 15, 2003.
Provost M. FDA Perspective on the Regulation of Biological/Device Combination Products. Regulatory Affairs Professional Society, Santa Clara, CA, May 24, 2004.
Provost M. Future Trends in Drug Delivery Systems. NIH Drug Delivery Symposium, Bethesda, MD, May 28, 2004.
Provost M. General, Restorative and Neurological Devises update. AdvaMed’s 14th Annual Workshop, Crystal City, VA, June 4, 2004.
Rechen EJ. Third Party Review of 510(k)s. Medical Design and Manufacturing (MD&M) Minneapolis Conference, Minneapolis, MN, October 28, 2003.
Rechen EJ. Use of Guidance and Standards in Premarket Review. Medical Design and Manufacturing (MD&M) Minneapolis Conference, Minneapolis, MN, October 28, 2003.
Rechen EJ. Third Party Review of 510(k)s: After MDUFMA. AdvaMed’s 14th Annual Device Submissions Workshop, Arlington, VA, June 3, 2004.
Rechen EJ. Use of Guidance and Standards in Premarket Review. Medical Design and Manufacturing (MD&M) East Conference, New York City, NY, June 14, 2004.
Rhodes S. FDA Perspective on the Regulation of Biomaterials in Plastic and Reconstructive Surgery Devices. 7th World Biomaterials Congress, Sidney, Australia, May 22, 2004.
Romanell L. "Filing a 513(g) Request," 14th Annual Device Submissions Workshop, AdvaMed, Washington, DC, June 3, 2004.
Romanell L. Co-Moderator, "510(k) Submissions 101," Educational Course, AdvaMed, Alexandria, VA, March 30-31, 2004.
Rosecrans HS. Premarket Notification Program. RAPS 2003 Annual Conference and Exhibition, Baltimore, MD, October 19-22, 2003.
Rosecrans HS. 510(k) Review Process. RAPS 510(k) Webcast Series, Rockville, MD, November 20, 2003.
Rosecrans HS. Premarket Notification Program. CDRH IVD Roundtable, 510(k)/OIVD Workshop, Rockville, MD, April 20-21, 2004.
Rosecrans HS. 510(k) Third Party Review Program. RAPS 2004 West Coast Symposium and Exhibit, Santa Clara, CA, May 25-26, 2004.
Rosecrans HS. 510(k) Program Update. 7th Annual FDA-Orange County Regulatory Affairs Educational Conference, Irvine, CA, June 2-3, 2004.
Rosecrans HS. MDUFMA 510(k) Guidance. AdvaMed’s 14th Annual Device Submission Workshop, Arlington, VA, June 4, 2004.
Rosecrans HS. 510(k) Program Update. NEMA’s RT Industry/Vendor Meeting, Pittsburgh, PA, July 27, 2004.
Rosecrans HS. Premarket Device Review Programs and Postmarket Surveillance. US FDA Seminars with UK Trade & Investment, London, England, UK, September 13-14, 2004, Leeds, England, UK, September 16-17, 2004, and Edinburgh, Scotland, UK, September 20-21, 2004.
Rosecrans HS. What Every Medical Technology Company Should Know About the 510(k) Program. Medical Device Manufacturer Association, Washington, DC, September 30-October 1, 2004.
Sacks W. Aspects of the FDA’s approach to evaluating CAD’s. Annual meeting of Computer Aided Radiology and Surgery, Chicago, IL, June, 2004.
Sauberman H. Connectivity Standards Utilizing Computers for Analyzing Data from Blood Glucose Monitors and Insulin Delivery Systems. Third Annual Diabetes Technology Meeting, San Diego, CA, November 6, 2003.
Sauberman H. The STED Initiative. The 2004 West Coast Symposium, Regulatory Affairs Professionals Society, Santa Clara, CA, May 26, 2004.
Sauberman H. Overview of STED Pilot Program and the Center’s Internal Evaluation Questionnaire. The 2004 Educational Conference, Association of Medical Diagnostics Manufacturers, La Jolla, CA, September 23-24, 2004.
Saviola J. The FDA from the Inside & Out - What works and What Doesn't Work. East-West Eye Conference, sponsored by the Ohio Optometric Association, Cleveland, OH, October 2003.
Saviola J. The FDA's Role in Human Subject Medical Device Clinical Studies. The Eye and the Chip 2004 Internation Symposium, sponsored by the Detroit Institute of Ophthalmology, Detroit, MI, June 2004.
Shulman M. Medical Device User Fee and Modernization Act. Advanced Issues in 510(k). Medical Design and Manufacturing (MD&M) Minneapolis, Minneapolis, MN, October 2003.
Shulman M. Basic 510(k) Overview. Advanced 510(k) Issues. Medical Design and Manufacturing (MD&M) West Conference, Anaheim, CA, January 2004.
Shulman M. Bringing Foreign Produced Devices to U.S. Markets. MEDTEC Germany 2004, Stuttgart, Germany, March 2004.
Shulman M. 510(k) Submission 101 Workshop. AdvaMed, Alexandria, VA, March 2004.
Shulman M. Basic Premarket Notification Overview. Advanced 510(k) Issues. Medical Design and Manufacturing (MD&M) East, New York, NY, June 2004.
Stiegman G. Post-approval Studies for Carotid Stents. Transcatheter Cardiovascular Therapeutics, Washington DC, September 29, 2004.
Stevens T. National Institute of Neurological Diseases and Stroke. Regulation of Medical Devices, Bethesda, MD, October 22, 2004.
Swain J. Medical Device Development: From Research to FDA Approval. NewEra Cardiac Care: Innovation & Technology, Dana Point, CA, January, 2004.
Swain J. What’s on the Horizon: Percutaneous Valves. Pathophysiology and Techniques of Cardiopulmonary Bypass, San Diego, CA, March, 2004.
Swain J. Regulatory Strategy for Acute Myocardial Infarction Devices. Trans Catheter Therapeutics meeting, Washington, DC, September 2004.
Swain J. Regulatory Strategy for Percutaneous Aortic and Mitral Valve Technologies. Trans Catheter Therapeutics meeting, Washington, DC, September 2004.
Turtil S. What’s New with Reprocessed SUDs. AdvaMed 14th Annual
Device Submissions Workshop “One and a Half Years After MDUFMA: What Has Changed?,” Arlington, VA, June 3, 2004.
Warburton K. FDA Update. American National Standards Institute (ANSI) Committee Z80 for Ophthalmic Device Standards, Ft. Lauderdale, FL, March 2004.
Whipple, DM. Ophthalmic Device Update, AdvaMed Medical Device Submission Workshop, Washington, DC, June 2004.
Whipple, DM. FDA Update. American National Standards Institute (ANSI) Committee Z80 for Ophthalmic Device Standards, Baltimore, MD, August 2004.
Witten CM. Regulation of Tissue Based Devices. Drug Information Association, Europe, Prague, Czech Republic, March 12, 2004.
Witten CM. Acute Stroke Treatment Trials: Enhancing Development, Corporation and Approval. Stroke Therapy Academic Industry Round table, Baltimore, MD, April 1-2, 2004.
Witten CM. Regulation of Neurological Devices. A Conversation with Neurological Disease Patient Advocacy Organization, Rockville, MD, April 24, 2004.
Witten CM. Device Regulatory Overview. American Association of Neurological Surgeons/Congress of Neurological Surgeons Meeting, Bethesda, MD, April 1-2, 2004.
Yustein A. Getting Involved with CDRH. 68th Annual Scientific Meeting of the American College of Gastroenterology (ACG): Breakfast Session, Baltimore, MD,
October 14, 2003.
Yustein A. FDA Approval Process for Medical Devices. ASGE Meeting, Chicago, IL, December 13, 2003.
Yustein A. “The FDA and GI Devices: Getting Your Product from Bench to Bedside” Mayo Clinic Innovations Initiative, Rochester, MN, July 26, 2004
Zimmerman BA. Regulatory Review of Spinal Devices. North American Spine Society, Boca Raton, FL, April 22–25, 2004.
Zuckerman B and Lochner D. Cardiovascular Devices Update. AdvaMed, Washington, DC, June 3, 2004.
Staff College Presenters and Faculty
| Ciarkowski, Art Chakrabarti, Kish Cotterell, Alison Gatling, Robert Hawthorn, Anne Jensen, D. Nick Kammula, Raju | Less, Joanne Lewis, Brian Mann, Eric Melkerson, Mark Neuland, Carolyn Nguyen, Thinh Pena, Carlos | Phillips, Philip Pluhowski, Nancy Provost, Miriam Rosecrans, Heather Sacks, William Wolanski, Nicole |
ODE Standards Liaison Representatives
| Abel, Dorothy Adjodha, Michael Allen, Peter Anderson, Jodi Baker, Karen Basu, Sankar Beers, Everette Berman, Michael Berman, Sheryl Bezabeh, Shewit Blackwell, Angela Brown, Daniel Burdick, William Byrd, Laura Calogero, Don Carey, Carole Chen, Tzeng Cheng, Jim Ciarkowski, Art Cornelius, Mary Jo Cunningham, Terrell Cygnarowicz, Teresa | Dawisha, Sahar Ferriter, Ann | Jensen, Nick Lepri, Bernard |
| Naveau, Irene Nell, Diane Nimmagadda, Venkat Nutter, Cathy Ogden, Neil O'Lone, Martha Phillips, Robert Pinto, Hina Pollard, Collin Rhodes, Stephen | Riley, Erin Rosenthal, Ralph Ryan, Michael Saviola, James Schmidt, Jennifer Schroeder, Marie Shein, Mitchell Shi, Dexiu Shih, Ming-Chuen Smith, Myra Stiegman, Glenn | Tillman, Donna-Bea Toy, Jeffrey Turtil, Steve Warburton, Karen Weitershausen, Joanna Wentz, Catherine Whipple, David Witten, Celia Wood, Geretta Zaremba, Loren |
